The worldwide Alzheimer's disease neuroimaging initiative: an update

Autores
Hendrix, James A.; Finger, Brad; Weiner, Michael W.; Frisoni, Giovanni B.; Iwatsubo, Takeshi; Rowe, Christopher C.; Kim, Seong Yoon; Guinjoan, Salvador Martín; Sevlever, Gustavo; Carrillo, Maria Cristina
Año de publicación
2015
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
The Alzheimer's Disease Neuroimaging Initiative (ADNI), launched in 2004, has worked to accelerate drug development by validating imaging and blood/cerebrospinal fluid biomarkers for Alzheimer's disease clinical treatment trials. ADNI is a naturalistic (nontreatment) multisite longitudinal study. A true public-private partnership, the initiative has set a new standard for data sharing without embargo and for the use of biomarkers in dementia research. The ADNI effort in North America is not the only such effort in the world. The Alzheimer's Association recognized these global efforts and formed Worldwide ADNI (WW-ADNI). By creating a platform for international collaboration and cooperation, WW-ADNI's goals are to harmonize projects and results across geographical regions and to facilitate data management and availability to investigators around the world. WW-ADNI projects include those based in North America, Europe, Japan, Australia, Korea, and Argentina.
Fil: Hendrix, James A.. Alzheimer's Association; Estados Unidos
Fil: Finger, Brad.
Fil: Weiner, Michael W.. University of California; Estados Unidos
Fil: Frisoni, Giovanni B.. Universidad de Ginebra; Suiza
Fil: Iwatsubo, Takeshi. University Hospital of Tokyo. Graduate School of Medicine. Department of Neuropathology; Japón
Fil: Rowe, Christopher C.. Austin Health. Department of Molecular Imaging; Australia
Fil: Kim, Seong Yoon. Asian Medical Center. Department of Psychiatry; Corea del Sur
Fil: Guinjoan, Salvador Martín. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Sevlever, Gustavo. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina
Fil: Carrillo, Maria Cristina. Alzheimer's Association; Estados Unidos
Materia
Alzheimer'S Disease
Neuroimaging
Biomarkers
Cerebrospinal Fluid
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/15955
Acceder
id CONICETDig_fa4bfa64c2ee1fe34b653bb11584d09d
oai_identifier_str oai:ri.conicet.gov.ar:11336/15955
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling The worldwide Alzheimer's disease neuroimaging initiative: an updateHendrix, James A.Finger, BradWeiner, Michael W.Frisoni, Giovanni B.Iwatsubo, TakeshiRowe, Christopher C.Kim, Seong YoonGuinjoan, Salvador MartínSevlever, GustavoCarrillo, Maria CristinaAlzheimer'S DiseaseNeuroimagingBiomarkersCerebrospinal Fluidhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3The Alzheimer's Disease Neuroimaging Initiative (ADNI), launched in 2004, has worked to accelerate drug development by validating imaging and blood/cerebrospinal fluid biomarkers for Alzheimer's disease clinical treatment trials. ADNI is a naturalistic (nontreatment) multisite longitudinal study. A true public-private partnership, the initiative has set a new standard for data sharing without embargo and for the use of biomarkers in dementia research. The ADNI effort in North America is not the only such effort in the world. The Alzheimer's Association recognized these global efforts and formed Worldwide ADNI (WW-ADNI). By creating a platform for international collaboration and cooperation, WW-ADNI's goals are to harmonize projects and results across geographical regions and to facilitate data management and availability to investigators around the world. WW-ADNI projects include those based in North America, Europe, Japan, Australia, Korea, and Argentina.Fil: Hendrix, James A.. Alzheimer's Association; Estados UnidosFil: Finger, Brad.Fil: Weiner, Michael W.. University of California; Estados UnidosFil: Frisoni, Giovanni B.. Universidad de Ginebra; SuizaFil: Iwatsubo, Takeshi. University Hospital of Tokyo. Graduate School of Medicine. Department of Neuropathology; JapónFil: Rowe, Christopher C.. Austin Health. Department of Molecular Imaging; AustraliaFil: Kim, Seong Yoon. Asian Medical Center. Department of Psychiatry; Corea del SurFil: Guinjoan, Salvador Martín. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Sevlever, Gustavo. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; ArgentinaFil: Carrillo, Maria Cristina. Alzheimer's Association; Estados UnidosElsevier Inc2015-07info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/15955Hendrix, James A.; Finger, Brad; Weiner, Michael W.; Frisoni, Giovanni B.; Iwatsubo, Takeshi; et al.; The worldwide Alzheimer's disease neuroimaging initiative: an update; Elsevier Inc; Alzheimers & Dementia; 11; 7; 7-2015; 850-8591552-5260enginfo:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S1552526015001752info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jalz.2015.05.008info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:00:03Zoai:ri.conicet.gov.ar:11336/15955instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:00:03.864CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv The worldwide Alzheimer's disease neuroimaging initiative: an update
title The worldwide Alzheimer's disease neuroimaging initiative: an update
spellingShingle The worldwide Alzheimer's disease neuroimaging initiative: an update
Hendrix, James A.
Alzheimer'S Disease
Neuroimaging
Biomarkers
Cerebrospinal Fluid
title_short The worldwide Alzheimer's disease neuroimaging initiative: an update
title_full The worldwide Alzheimer's disease neuroimaging initiative: an update
title_fullStr The worldwide Alzheimer's disease neuroimaging initiative: an update
title_full_unstemmed The worldwide Alzheimer's disease neuroimaging initiative: an update
title_sort The worldwide Alzheimer's disease neuroimaging initiative: an update
dc.creator.none.fl_str_mv Hendrix, James A.
Finger, Brad
Weiner, Michael W.
Frisoni, Giovanni B.
Iwatsubo, Takeshi
Rowe, Christopher C.
Kim, Seong Yoon
Guinjoan, Salvador Martín
Sevlever, Gustavo
Carrillo, Maria Cristina
author Hendrix, James A.
author_facet Hendrix, James A.
Finger, Brad
Weiner, Michael W.
Frisoni, Giovanni B.
Iwatsubo, Takeshi
Rowe, Christopher C.
Kim, Seong Yoon
Guinjoan, Salvador Martín
Sevlever, Gustavo
Carrillo, Maria Cristina
author_role author
author2 Finger, Brad
Weiner, Michael W.
Frisoni, Giovanni B.
Iwatsubo, Takeshi
Rowe, Christopher C.
Kim, Seong Yoon
Guinjoan, Salvador Martín
Sevlever, Gustavo
Carrillo, Maria Cristina
author2_role author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Alzheimer'S Disease
Neuroimaging
Biomarkers
Cerebrospinal Fluid
topic Alzheimer'S Disease
Neuroimaging
Biomarkers
Cerebrospinal Fluid
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv The Alzheimer's Disease Neuroimaging Initiative (ADNI), launched in 2004, has worked to accelerate drug development by validating imaging and blood/cerebrospinal fluid biomarkers for Alzheimer's disease clinical treatment trials. ADNI is a naturalistic (nontreatment) multisite longitudinal study. A true public-private partnership, the initiative has set a new standard for data sharing without embargo and for the use of biomarkers in dementia research. The ADNI effort in North America is not the only such effort in the world. The Alzheimer's Association recognized these global efforts and formed Worldwide ADNI (WW-ADNI). By creating a platform for international collaboration and cooperation, WW-ADNI's goals are to harmonize projects and results across geographical regions and to facilitate data management and availability to investigators around the world. WW-ADNI projects include those based in North America, Europe, Japan, Australia, Korea, and Argentina.
Fil: Hendrix, James A.. Alzheimer's Association; Estados Unidos
Fil: Finger, Brad.
Fil: Weiner, Michael W.. University of California; Estados Unidos
Fil: Frisoni, Giovanni B.. Universidad de Ginebra; Suiza
Fil: Iwatsubo, Takeshi. University Hospital of Tokyo. Graduate School of Medicine. Department of Neuropathology; Japón
Fil: Rowe, Christopher C.. Austin Health. Department of Molecular Imaging; Australia
Fil: Kim, Seong Yoon. Asian Medical Center. Department of Psychiatry; Corea del Sur
Fil: Guinjoan, Salvador Martín. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Sevlever, Gustavo. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina
Fil: Carrillo, Maria Cristina. Alzheimer's Association; Estados Unidos
description The Alzheimer's Disease Neuroimaging Initiative (ADNI), launched in 2004, has worked to accelerate drug development by validating imaging and blood/cerebrospinal fluid biomarkers for Alzheimer's disease clinical treatment trials. ADNI is a naturalistic (nontreatment) multisite longitudinal study. A true public-private partnership, the initiative has set a new standard for data sharing without embargo and for the use of biomarkers in dementia research. The ADNI effort in North America is not the only such effort in the world. The Alzheimer's Association recognized these global efforts and formed Worldwide ADNI (WW-ADNI). By creating a platform for international collaboration and cooperation, WW-ADNI's goals are to harmonize projects and results across geographical regions and to facilitate data management and availability to investigators around the world. WW-ADNI projects include those based in North America, Europe, Japan, Australia, Korea, and Argentina.
publishDate 2015
dc.date.none.fl_str_mv 2015-07
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/15955
Hendrix, James A.; Finger, Brad; Weiner, Michael W.; Frisoni, Giovanni B.; Iwatsubo, Takeshi; et al.; The worldwide Alzheimer's disease neuroimaging initiative: an update; Elsevier Inc; Alzheimers & Dementia; 11; 7; 7-2015; 850-859
1552-5260
url http://hdl.handle.net/11336/15955
identifier_str_mv Hendrix, James A.; Finger, Brad; Weiner, Michael W.; Frisoni, Giovanni B.; Iwatsubo, Takeshi; et al.; The worldwide Alzheimer's disease neuroimaging initiative: an update; Elsevier Inc; Alzheimers & Dementia; 11; 7; 7-2015; 850-859
1552-5260
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S1552526015001752
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jalz.2015.05.008
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Elsevier Inc
publisher.none.fl_str_mv Elsevier Inc
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842269617185095680
score 13.13397

Publicaciones similares